Big Pharma Voluntary List Price Reductions Doubtful, Sen. Warren Says

Companies responding to inquiries from Sens. Elizabeth Warren, D-Mass., and Tina Smith, D-Minn., did not indicate they are planning to reduce list prices, despite promises by President Trump, Warren told a June 12 hearing. 

Businesswoman Hands On Crystal Ball On Black Background. Fortune Teller Predicting Future

More from Drug Pricing

More from Scrip